You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for TOLNAFTATE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TOLNAFTATE

Best Wholesale Price for TOLNAFTATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TOLNAFTATE 1% CREAM,TOP Golden State Medical Supply, Inc. 51672-2020-01 15GM 1.02 0.06800 GM 2023-06-15 - 2028-06-14 FSS
TOLNAFTATE 1% CREAM,TOP Golden State Medical Supply, Inc. 51672-2020-02 30GM 4.81 0.16033 GM 2023-06-15 - 2028-06-14 FSS
TOLNAFTATE 1% PWDR,TOP Geri-Care Pharmaceutical Corp 57896-0199-45 45GM 1.75 0.03889 GM 2021-06-15 - 2026-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Tolnaftate Market Analysis and Price Projections

Market Overview

Tolnaftate, an antifungal agent, is widely used in over-the-counter (OTC) topical antifungal products. The market for tolnaftate is experiencing significant growth driven by several key factors.

Global Market Size and Growth

The global tolnaftate market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 1.8 billion by 2032, growing at a substantial CAGR[1][4].

Regional Market Dynamics

The U.S. OTC topical antifungals market, which includes tolnaftate, is also expected to grow significantly. This market is anticipated to expand at a CAGR of 3.6% from 2023 to 2031, reaching more than USD 1.8 billion by the end of 2031[3].

Drivers of Market Growth

Increase in Fungal Infections

The rise in prevalence of fungal infections is a major driver for the tolnaftate market. As fungal infections become more common, the demand for effective antifungal treatments like tolnaftate increases[3].

Awareness and Adoption

Increased awareness among consumers about the effectiveness of OTC topical antifungals, including tolnaftate, is another significant factor. Early adoption of latest technologies and the presence of key industry players also contribute to market growth[3].

Geriatric Population

The rise in the geriatric population is another contributing factor. Older adults are more susceptible to fungal infections, which in turn drives the demand for antifungal treatments[3].

Market Segmentation

By Drug Class

The U.S. OTC topical antifungals market, which includes tolnaftate, is segmented by drug class. Tolnaftate falls under the category of other antifungals, distinct from azoles and allylamines. The market value share analysis by drug class indicates that while azoles dominate the market, tolnaftate and other antifungals also hold significant shares[3].

By Indication

Tolnaftate is used for various indications, including athlete's foot, jock itch, and ringworm. The market is segmented by these indications, with each segment contributing to the overall growth of the tolnaftate market[3].

By Dosage Form

The market is also segmented by dosage form, including creams, powders, and sprays. The convenience and efficacy of these forms influence consumer preferences and market dynamics[3].

Competitive Landscape

Key Players

The tolnaftate market is competitive, with key players such as Novartis AG, Merck KGaA, Dr Reddy’s Laboratories Ltd., Pfizer, Inc., Abbott Laboratories, Bayer AG, Sanofi, and Crown. These companies are profiled based on parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments[3].

Pricing Analysis

Market Forecast

The pricing of tolnaftate products is influenced by market dynamics, competition, and regulatory factors. The U.S. OTC topical antifungals market forecast indicates a steady increase in market size, which is likely to impact pricing strategies. As the market grows, companies may adjust prices to maintain profitability while remaining competitive[3].

Impact of COVID-19

Short, Mid, and Long Term Impact

The COVID-19 pandemic had a significant impact on the healthcare sector, including the OTC topical antifungals market. In the short term, there was a surge in demand for antifungal products due to increased awareness of personal health. In the mid and long term, the market is expected to continue growing as consumers maintain a focus on health and hygiene[3].

Regional Insights

Global vs. U.S. Market

While the global tolnaftate market is projected to grow significantly, the U.S. market is particularly noteworthy due to its large size and high growth rate. The U.S. market benefits from early adoption of technologies and the presence of major industry players[1][3].

Future Outlook

CAGR and Market Size

The global tolnaftate market is expected to grow at a substantial CAGR, reaching USD 1.8 billion by 2032. This growth is driven by increasing demand, technological advancements, and expanding distribution channels[1][4].

Technological Advancements

Advancements in formulation and delivery systems are expected to enhance the efficacy and convenience of tolnaftate products, further driving market growth.

Distribution Channels

The expansion of distribution channels, including online pharmacies and retail stores, is making tolnaftate products more accessible to consumers, contributing to market expansion[3].

Key Takeaways

  • The global tolnaftate market is projected to reach USD 1.8 billion by 2032.
  • The U.S. OTC topical antifungals market, including tolnaftate, is expected to grow at a CAGR of 3.6% from 2023 to 2031.
  • Increase in fungal infections, consumer awareness, and the geriatric population are key drivers of market growth.
  • The market is segmented by drug class, indication, and dosage form.
  • Key players in the market include major pharmaceutical companies like Novartis AG and Pfizer, Inc.

FAQs

What is the projected global market size for tolnaftate by 2032?

The global market size for tolnaftate is projected to reach USD 1.8 billion by 2032[1].

What is the CAGR of the U.S. OTC topical antifungals market from 2023 to 2031?

The U.S. OTC topical antifungals market is expected to grow at a CAGR of 3.6% from 2023 to 2031[3].

What are the main drivers of the tolnaftate market growth?

The main drivers include the increase in fungal infections, rise in consumer awareness, and the growing geriatric population[3].

Who are the key players in the tolnaftate market?

Key players include Novartis AG, Merck KGaA, Dr Reddy’s Laboratories Ltd., Pfizer, Inc., Abbott Laboratories, Bayer AG, Sanofi, and Crown[3].

How has the COVID-19 pandemic impacted the tolnaftate market?

The COVID-19 pandemic has increased demand for antifungal products in the short term and is expected to contribute to long-term growth as consumers focus on health and hygiene[3].

Sources

  1. Dataintelo, "Tolnaftate Market Research Report 2032".
  2. Global Market Vision, "Global Tolnaftate Market Recent Trends, In-depth Analysis, Size and Forecast".
  3. Transparency Market Research, "U.S. OTC Topical Antifungals Market Size, Share & Forecast - 2031".
  4. News Channel Nebraska, "Tolnaftate Market is anticipated to boost sales at a Impressive CAGR".
  5. 24 Chemical Research, "Tolnaftate Market, Global Outlook and Forecast 2022-2028".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.